MassBio represents 1,200+ life sciences companies and organizations involved with the industry. We are available to comment and provide background on public policy, economic development, education, workforce development and other key life sciences issues.
The requirement to disclose list prices in TV ads was blocked; President Trump withdrew his policy to eliminate PBM rebates; & several drug pricing bills were advanced. In MA, PBMs come under scrutiny Read More
Spilka Says she has the Support to Become Next Senate President; DeLeo Reconfirms House Health Care Bill Will Emerge in the Coming Months; Trump Announces his Plan to Address Opioid Addiction Read More